-
MREO Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Mereo BioPharma (MREO)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 80.52 mm | 80.52 mm | 80.52 mm | 80.52 mm | 80.52 mm | 80.52 mm |
Cash burn (monthly) | 2.30 mm | (no burn) | 5.00 mm | 3.95 mm | 66.00 k | 717.67 k |
Cash used (since last report) | 9.28 mm | n/a | 20.15 mm | 15.90 mm | 265.97 k | 2.89 mm |
Cash remaining | 71.24 mm | n/a | 60.37 mm | 64.62 mm | 80.26 mm | 77.63 mm |
Runway (months of cash) | 30.9 | n/a | 12.1 | 16.4 | 1216.0 | 108.2 |
13F holders | Current |
---|---|
Total holders | 79 |
Opened positions | 11 |
Closed positions | 13 |
Increased positions | 19 |
Reduced positions | 24 |
13F shares | Current |
---|---|
Total value | 432.94 bn |
Total shares | 113.73 mm |
Total puts | 479.10 k |
Total calls | 208.70 k |
Total put/call ratio | 2.3 |
Largest owners | Shares | Value |
---|---|---|
Rubric Capital Management | 15.31 mm | $62.91 bn |
JHG Janus Henderson | 12.35 mm | $50.86 bn |
Adage Capital Partners GP, L.L.C. | 9.72 mm | $39.93 bn |
Rock Springs Capital Management | 9.53 mm | $39.19 bn |
Mangrove Partners | 8.73 mm | $35.88 bn |
Deerfield Management | 6.71 mm | $27.58 bn |
Millennium Management | 5.39 mm | $22.17 bn |
Frazier Life Sciences Management | 5.10 mm | $20.95 bn |
683 Capital Management | 4.85 mm | $19.93 bn |
Alkeon Capital Management | 4.70 mm | $19.31 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Jan 25 | John A. Lewicki | Share Options American Depository Shares | Grant | Acquire A | No | No | 2.91 | 116,000 | 337.56 k | 116,000 |
25 Jan 25 | Chrisitne Ann Fox | Share Options American Depository Shares | Grant | Acquire A | No | No | 2.91 | 262,000 | 762.42 k | 262,000 |
25 Jan 25 | Charles Sermon | Share Options American Depository Shares | Grant | Acquire A | No | No | 2.91 | 262,000 | 762.42 k | 262,000 |
25 Jan 25 | Denise Scots-Knight | Share Options American Depository Shares | Grant | Acquire A | No | No | 2.91 | 825,000 | 2.40 mm | 825,000 |
25 Jan 25 | Alexandra Hughes-Wilson | Share Options American Depository Shares | Grant | Acquire A | No | No | 2.91 | 154,000 | 448.14 k | 154,000 |